Literature DB >> 2690045

Problems in the management of myeloma.

J S Malpas1.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2690045      PMCID： PMC2429432          DOI： 10.1136/pgmj.65.765.468

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  16 in total

1.  Actions of recombinant interleukin 1, interleukin 2, and interferon-gamma on bone resorption in vitro.

Authors:  M Gowen; G R Mundy
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

2.  The development of high dose melphalan and of autologous bone marrow transplantation in the treatment of multiple myeloma: Royal Marsden and St Bartholomew's Hospital studies.

Authors:  P Selby; G Zulian; G Forgeson; A Nandi; S Milan; M Meldrum; C Viner; R Osborne; J S Malpas; T J McElwain
Journal:  Hematol Oncol       Date:  1988 Apr-Jun       Impact factor: 5.271

3.  Chemotherapy of myeloma: drug combinations versus single agents, an overview, and comments on acute leukemia in myeloma.

Authors:  D E Bergsagel
Journal:  Hematol Oncol       Date:  1988 Apr-Jun       Impact factor: 5.271

4.  Effective treatment of advanced multiple myeloma refractory to alkylating agents.

Authors:  B Barlogie; L Smith; R Alexanian
Journal:  N Engl J Med       Date:  1984-05-24       Impact factor: 91.245

5.  Smoldering multiple myeloma.

Authors:  R A Kyle; P R Greipp
Journal:  N Engl J Med       Date:  1980-06-12       Impact factor: 91.245

6.  Multiple myeloma: review of 869 cases.

Authors:  R A Kyle
Journal:  Mayo Clin Proc       Date:  1975-01       Impact factor: 7.616

7.  Localized and indolent myeloma.

Authors:  R Alexanian
Journal:  Blood       Date:  1980-09       Impact factor: 22.113

8.  Monoclonal gammopathy of undetermined significance. Natural history in 241 cases.

Authors:  R A Kyle
Journal:  Am J Med       Date:  1978-05       Impact factor: 4.965

9.  Effects of dichloromethylene diphosphonate on skeletal mobilization of calcium in multiple myeloma.

Authors:  E S Siris; W H Sherman; D C Baquiran; J P Schlatterer; E F Osserman; R E Canfield
Journal:  N Engl J Med       Date:  1980-02-07       Impact factor: 91.245

10.  Report on the second myelomatosis trial after five years of follow-up. Medical Research Council's Working Party on Leukaemia in Adults.

Authors: 
Journal:  Br J Cancer       Date:  1980-12       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.